APA (7th ed.) Citation

Pathmanandavel, S., Crumbaker, M., Ho, B., Yam, A. O., Wilson, P., Niman, R., . . . Emmett, L. (2022). Evaluation of 177Lu-PSMA SPECT Quantitation as a Response Biomarker within a Prospective 177Lu-PSMA-617 and NOX66 Combination Trial (LuPIN). Journal of Nuclear Medicine, 63(10), 1. https://doi.org/10.2967/jnumed.122.264398

Chicago Style (17th ed.) Citation

Pathmanandavel, Sarennya, et al. "Evaluation of 177Lu-PSMA SPECT Quantitation as a Response Biomarker Within a Prospective 177Lu-PSMA-617 and NOX66 Combination Trial (LuPIN)." Journal of Nuclear Medicine 63, no. 10 (2022): 1. https://doi.org/10.2967/jnumed.122.264398.

MLA (9th ed.) Citation

Pathmanandavel, Sarennya, et al. "Evaluation of 177Lu-PSMA SPECT Quantitation as a Response Biomarker Within a Prospective 177Lu-PSMA-617 and NOX66 Combination Trial (LuPIN)." Journal of Nuclear Medicine, vol. 63, no. 10, 2022, p. 1, https://doi.org/10.2967/jnumed.122.264398.